Banner

Pioneering innovative strategies to cure life threatening infectious and metabolic disease

Advancing a One Shot Cure for HIV-1 Infection

Glowing human DNA strands floating in mid air having a segment of the gene being hold by tweezers on dark background. Illustration of the concept of genetic engineering and gene therapy

Text + image

<h2 style="white-space:pre-line">About Us</h2>
<p><br />Marguron, Inc. is exploiting breakthrough gene therapy based single shot curative treatments. Our initial focus is preventing and curing HIV-1 infection. </p>
<p>HIV/AIDS remains one of the most significant infectious disease threats to the population. Globally, 40 million people were living with HIV-1 in 2023. That year saw 1.3 million new infections and 630,000 deaths from AIDS-related diseases. In developed (G9) regions, 3.1 million people live with HIV. While advances in antiretroviral therapy (ART) have markedly improved the outlook for people living with HIV, the stark global statistics reflect the challenges with implementing ART, as well as the realization that this modality is not curative. The advent of long-acting ART formulations is unlikely to provide a permanent solution, as these cost- and resource burdensome therapies require life long administrations.</p>
<p>For this reason, Marguron is disrupting the status quo by developing curative modalities. Our approach is to make reality: </p>
<p>"One Shot and You are Good for Life"</p>

Medical banner illustration with RNA strand. Coronavirus disease COVID-19 outbreak.

Location

Contact form

<h3>Contact Us</h3>
<p>Please use the contact form at the right or email info(at)marguron.com </p>